Sort   by:  
 Page size 
MetabolomicsUrolithin A (UroA) acts at CYP1A1/1B1 substrates leading to enhanced aryl hydrocarbon receptor (AHR) activity in vivo
Not available
ORGANISM(S): Mus musculus 
ST002481 | MetabolomicsWorkbench
TranscriptomicsGene expression after 24h Urolithin A incubation in LNCaP cells
The identification of new agents that may modulate the progression of cancer cell growth is of great interest. In this regard, dietary agents can be utilized to identify molecular targets to be used as part of a chemopreventive strategy. Walnuts contain several bioactive compounds, including peduncu...
ORGANISM(S): Homo sapiens 
2016-07-27 | E-GEOD-65527 | biostudies-arrayexpress
ProteomicsUntargeted proteomics of Enterocloster asparagiformis, E. citroniae, E. pacaense treated with DMSO or urolithin M6
Urolithins are a class of bioactive metabolites derived from the metabolism of dietary ellagitannins by the human gut microbiota. In the gut, urolithins are dehydroxylated regioselectively based on microbiota composition and activity. A single 9-hydroxy urolithin dehydroxylase (ucd) operon in gut re...
ORGANISM(S): Enterocloster hominis (ex Hitch et al. 2024) Enterocloster citroniae Enterocloster asparagiformis Bacteria 
2025-11-12 | PXD066865 | Pride
Microbiome Dmso M6 Bacteria Enterocloster Urolithin 
ProteomicsCombination Therapy with Nisin, Urolithin B, and Vincristine Exhibits Synergistic Antiproliferative and Pro-Apoptotic Effects Against Human Lymphoma Cells: Evidence From Proteomics
This study investigates the synergistic antitumor efficacy of a triple combination therapy—Nisin (N), Urolithin B (UB), and Vincristine (Vinc)—against human HBK11 lymphoma cells, with an emphasis on proteomic mechanisms of action. The findings elucidate the molecular underpinnings of this novel comb...
ORGANISM(S): Homo sapiens (Human) 
2025-09-19 | PXD065631 | Pride
Vincristine Urolithin b Synergy Apoptosis Nisin Proteomics Lymphoma 
GenomicsEffect of IAPP insult and urolithin B treatment in beta-cell gene expression
Effect of IAPP insult and urolithin B treatment in beta-cell gene expression
PRJNA902412 | ENA
GenomicsEffects of urolithin B treatment on gene expression of IAPP-expressing yeast cells
Effects of urolithin B treatment on gene expression of IAPP-expressing yeast cells
PRJNA902415 | ENA
TranscriptomicsEffect of IAPP insult and urolithin B treatment in beta-cell gene expression
To investigate the effects of IAPP insult and urolithin B treatment in the gene expression of a rodent cell line, we submitted the cells to different treatments: control, urolithin B, IAPP, annd urolithin B+IAPP
ORGANISM(S): Rattus norvegicus 
2025-12-31 | GSE218150 | GEO
TranscriptomicsEffects of urolithin B treatment on gene expression of IAPP-expressing yeast cells
To investigate the effects of ppIAPP-GFP expression and urolithin B treatment in the gene expression of Saccharomyces cerevisiae cells, we compared different cells: cells expressing the empty vector, cells expressing ppIAPP-GFP, cells expressing the empty vector treated with urolithin B, cells expre...
ORGANISM(S): Saccharomyces cerevisiae 
2022-11-24 | GSE218152 | GEO
UnknownUrolithin B, a newly identified regulator of skeletal muscle mass.
Not available
S-EPMC5566634 | biostudies-literature
UnknownUrolithin B: Two-way attack on IAPP proteotoxicity with implications for diabetes.
Not available
S-EPMC9797523 | biostudies-literature
Sort   by:  
 Page size